BCA
SBIO icon

Bay Colony Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bay Colony Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-775
Closed -$29K – 764
2018
Q2 		$29K Buy
+775
New +$28.1K 0.02% 455

Other funds holding SBIO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BCM
Barometer Capital Management Toronto, Ontario, Canada $292M AUM 86.78% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bay Colony Advisors's SBIO Position: Q3 2018 in Review

Bay Colony Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2018, closing a stake of 775 shares — an estimated $29K sold.

Bay Colony Advisors first reported a position in SBIO in Q2 2018 and held it in 1 quarter. The position peaked at $29K in Q2 2018. 55 funds tracked by Wall St. Rank hold SBIO as of Q3 2018.

  • Bay Colony Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2018 after selling out during the quarter.
  • Bay Colony Advisors sold 775 ALPS Medical Breakthroughs ETF shares in Q3 2018, an estimated $29K.
  • Bay Colony Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q2 2018 and held it in 1 quarter.
  • Bay Colony Advisors's ALPS Medical Breakthroughs ETF position peaked at $29K in Q2 2018.
  • 55 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2018.

Based on Bay Colony Advisors's 13F filing for Q3 2018, filed 5 Nov 2018.